Intuitive Surgical Management Discusses Q2 2012 Results - Earnings Call Transcript

Intuitive Surgical (ISRG)

Q2 2012 Earnings Call

July 19, 2012 4:30 pm ET

Executives

Calvin Darling

Gary S. Guthart - Chief Executive Officer, President and Director

Marshall L. Mohr - Chief Financial Officer, Principal Accounting Officer and Senior Vice President

Aleks Cukic - Vice President of Strategy

Analysts

Ben Andrew - William Blair & Company L.L.C., Research Division

Lennox Ketner - BofA Merrill Lynch, Research Division

Tycho W. Peterson - JP Morgan Chase & Co, Research Division

David R. Lewis - Morgan Stanley, Research Division

Lawrence S. Keusch - Raymond James & Associates, Inc., Research Division

Jose T. Haresco - JMP Securities LLC, Research Division

Presentation

Operator

Compare to:
Previous Statements by ISRG
» Intuitive Surgical's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Intuitive Surgical's CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Intuitive Surgical's CEO Discusses Q3 2011 Results - Earnings Call Transcript

Ladies and gentlemen, thank you for standing by. And welcome to the Intuitive Surgical Q2 2012 Earnings Release Call. [Operator Instructions] As a reminder, this call is being recorded. I'd now like to turn the conference over to Calvin Darling, Senior Director, Investor Relations for Intuitive Surgical. Please go ahead.

Calvin Darling

Thank you, and good afternoon. Welcome to Intuitive Surgical's second quarter conference call.

With me today, we have Gary Guthart, our President and CEO; Marshall Mohr, our Chief Financial Officer; and Aleks Cukic, our Vice President of Strategic Planning.

Before we begin, I would like to inform you that comments mentioned on today's call may be deemed to contain forward-looking statements. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties. These risks and uncertainties are described in detail in the company's Securities and Exchange Commission filings. Prospective investors are cautioned not to place undue reliance on such forward-looking statements.

1 2 3 Next › Last »